Larimar Therapeutics (LRMR) Retained Earnings (2016 - 2020)
Historic Retained Earnings for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to -$51.4 million.
- Larimar Therapeutics' Retained Earnings rose 8678.75% to -$51.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$51.4 million, marking a year-over-year increase of 8678.75%. This contributed to the annual value of -$23.1 million for FY2019, which is 9340.87% up from last year.
- According to the latest figures from Q3 2020, Larimar Therapeutics' Retained Earnings is -$51.4 million, which was up 8678.75% from -$41.1 million recorded in Q2 2020.
- Larimar Therapeutics' 5-year Retained Earnings high stood at -$23.1 million for Q4 2019, and its period low was -$399.9 million during Q1 2020.
- Over the past 5 years, Larimar Therapeutics' median Retained Earnings value was -$276.5 million (recorded in 2017), while the average stood at -$258.6 million.
- In the last 5 years, Larimar Therapeutics' Retained Earnings tumbled by 6608.78% in 2016 and then surged by 9340.87% in 2019.
- Quarter analysis of 5 years shows Larimar Therapeutics' Retained Earnings stood at -$237.5 million in 2016, then dropped by 21.9% to -$289.6 million in 2017, then dropped by 21.19% to -$350.9 million in 2018, then skyrocketed by 93.41% to -$23.1 million in 2019, then crashed by 122.25% to -$51.4 million in 2020.
- Its Retained Earnings was -$51.4 million in Q3 2020, compared to -$41.1 million in Q2 2020 and -$399.9 million in Q1 2020.